Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger protein 587 (ZNF587) is a DNA-binding transcription factor of the Krüppel-associated box (KRAB) C2H2-type zinc finger protein family, primarily involved in sequence-specific repression of transcription by RNA polymerase II[1][2][4][6][7]. ZNF587 binds and represses transposable elements and endogenous retrovirus (ERV) sequences in the human genome, contributing to epigenetic regulation, particularly in neural tissues and during development[2]. ZNF587, along with its paralog ZNF417, is evolutionarily recent and primate-specific, functioning as part of a species-specific layer of gene regulation that shapes neuronal gene expression through epigenetic silencing of target elements[2]. Loss of ZNF587 deregulates expression of certain TEs and downstream neuronal genes, potentially affecting the expression of genes like PRODH and AADAT in the brain; however, direct involvement in disease processes or as a pharmacological target has not been established[2][1][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger protein 587 (ZNF587).